J Kenneth Gibson

Title: J Kenneth Gibson: Innovator in Antiarrhythmic Compounds

Introduction

J Kenneth Gibson is a notable inventor based in Kalamazoo, MI (US). He has made significant contributions to the field of pharmacology, particularly in the development of antiarrhythmic agents. With a total of 2 patents, his work has had a meaningful impact on cardiac health.

Latest Patents

Gibson's latest patents include the development of antiarrhythmic (S)-enantiomers of methanesulfonamides. These compounds are structurally depicted by Formula I' and its pharmacologically acceptable salts. The compounds are characterized by R3 being a C1-7 alkyl substituted with C3-7 cycloalkyl, or a C1-10 alkyl with various fluorine and hydroxy substituents. These methanesulfonamides are recognized for their stability against rapid metabolism and their utility as Class III antiarrhythmic agents. Methods for treating cardiac arrhythmias using these compounds are also described in his patents.

Career Highlights

Throughout his career, J Kenneth Gibson has worked with prominent companies such as The Upjohn Company and Pharmacia & Upjohn Company. His expertise in pharmacology has allowed him to contribute to the development of innovative medical solutions.

Collaborations

Gibson has collaborated with notable coworkers, including Jackson B Hester, Jr. and Salvatore Charles Perricone. Their combined efforts have further advanced the research and development of antiarrhythmic compounds.

Conclusion

J Kenneth Gibson's contributions to the field of pharmacology, particularly in antiarrhythmic agents, highlight his innovative spirit and dedication to improving cardiac health. His patents and collaborations reflect a commitment to advancing medical science.